Call for your appointment today 914-666-4665 | Mt. Kisco, New York
Congratulations are also in order for Congressman Chris Smith, NJ for all his years of support and work on making this bill. Congressman Sean Maloney, NY and Wolf, VA are to be thanked for their leadership as well. Steve Bulger, District Director, Congressman Chris, Gibson – NY 19th CD, 518-610-8133 (office) Thanks are also in order […]
Over the past five years, the number of black-legged ticks (Ixodes scapularis), also known as deer ticks, in Ohio has exploded, and in turn, caused the number of reported Lyme disease cases to double, according to a new study conducted by Ohio State University and the Ohio Department of Health. [1] The authors in the
Lyme disease expected to be epidemic in Ohio Read More »
One study found that more than 1/3 of patients with chronic neurologic Lyme disease suffered from depression, in addition to fatigue, headaches, poor concentration, lightheadedness, and joint pain. While depression is not uncommon in patients with chronic illness, it does seem to be more prevalent among patients with Lyme disease, according to Dr. Robert Bransfield,
Lyme disease patients may struggle with depression Read More »
Physicians have been disappointed by the poor sensitivity of the EIA or IFA screening tests for Lyme disease. The sensitivity of the whole-cell enzyme-linked immunosorbent assay (ELISA) to the B31 strain typically falls between 33-49% for patients presenting with an EM.[2-4] The sensitivity of the Food and Drug Administration (FDA) approved complement peptide C6 (C6-peptide)
LabCorp to deny physicians access to western blot tests for Lyme disease Read More »
Senator Schumer addressed the shortage of doxycycline in his August 12, 2004 press conference in the Hudson Valley, New York. His comment included the following “LOOMING SHORTAGE OF DOXYCYCLINE, AN ANTIBIOTIC USED TO TREAT LYME DISEASE, IS SENDING PRICE OF DRUG SKYROCKETING DURING ONE OF WORST LYME SEASONS – SENATOR CALLS ON FDA TO INVESTIGATE
Senator Schumer joins the Lyme disease community in addressing oral antibiotic shortages Read More »
For Immediate Release: For Information or Interview Requests Contact: Sue Ferrara, PhD pressinfo@ilads.org (609) 947-9489 Back to School: The ABCs of Lyme and other Tick-borne Infections As families transition from summer activities to Back-to-School preparations, the International Lyme and Associated Diseases Society (ILADS) urges parent to think about where their children have been this summer;
ILADS reminds parents of the ABCs of Lyme and other Tick-borne Infections Read More »
The ILADS 2014 treatment guidelines for Lyme disease identified a number of key issues in making these recommendations: Lyme disease is a complex illness and patients may experience both acute and persistent manifestations Persistent manifestations may produce profound quality-of-life impairments, yet the mechanisms that produce persistent manifestations are poorly understood. The available evidence regarding the
Why ILADS 2014 treatment guidelines are important Read More »
by Daniel J. Cameron, MD MPH A cross-sectional pilot study carried out in the Breakspear neuroscience department in the United Kingdom reported that 50% of 16 serologically positive Lyme disease patients had a loss of libido compared to 0% in 18 controls (p<.001) The loss of libido was not associated with detrusor muscle dysfunction or
Loss of libido and Lyme disease Read More »
A co-infection of Babesia with Lyme disease can increase the severity and duration of illness. Over 6% of questing Nymphal ticks were infected with the pathogens that cause Babesia and Lyme disease. Unfortunately, standard antibiotic treatments for Lyme disease such as doxycycline, amoxicillin, or zithromax are not effective for Babesia. Antiparasitic therapy with when added
Babesia becomes the Number 2 tick-borne illness behind Lyme disease in the Hudson Valley Read More »
Krause et al. reported that B. miyamotoi can cause illness and is treatable. Yet, Krause et al also reported that traditional tests for Borrelia burgdorferi (Bb) cannot be used to diagnose B. miyamotoi (B. Miyamotoi). [1] Dr. Lee, an investigator at the Department of Pathology, Milford Hospital, Connecticut described a novel DNA Sequencing test that
A new DNA sequence test for Borrelia burgdorferi and Borrelia miyamotoi Infections Read More »
